Literature DB >> 18945820

Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.

Sang Mi Shin1, Sang Geon Kim.   

Abstract

4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz), a prototype drug candidate containing a 1,2-dithiole-3-thione moiety, has been widely studied as a cancer chemopreventive agent. Oltipraz and other novel 1,2-dithiole-3-thione congeners have the capability to prevent insulin resistance via AMP-activated protein kinase (AMPK) activation. Arachidonic acid (AA, a proinflammatory fatty acid) exerts a deleterious effect on mitochondria and promotes reactive oxygen species (ROS) production. This study investigated whether AA alone or in combination with iron (catalyst of autooxidation) causes ROS-mediated mitochondrial impairment, and if so, whether oltipraz and synthetic 1,2-dithiole-3-thiones protect mitochondria and cells against excess ROS produced by AA + iron. Oltipraz treatment effectively inhibited mitochondrial permeability transition promoted by AA + iron in HepG2 cells, thereby protecting cells from ROS-induced apoptosis. Oltipraz was found to attenuate apoptosis induced by rotenone (complex I inhibitor), but not that by antimycin A (complex III inhibitor), suggesting that the inhibition of AA-induced apoptosis by oltipraz might be associated with the electron transport system. AMPK activation by oltipraz contributed to cell survival, which was supported by the reversal of oltipraz's restoration of mitochondrial membrane potential by concomitant treatment of compound C. By the same token, an AMPK activator inhibited AA + iron-induced mitochondrial permeability transition with an increase in cell viability. Moreover, new 1,2-dithiole-3-thiones with the capability of AMPK activation protected cells from mitochondrial permeability transition and ROS overproduction induced by AA + iron. Our results demonstrate that oltipraz and new 1,2-dithiole-3-thiones are capable of protecting cells from AA + iron-induced ROS production and mitochondrial dysfunction, which may be associated with AMPK activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945820     DOI: 10.1124/mol.108.051128

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

1.  Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways.

Authors:  Ruo-ming Wu; Yan-yan Sun; Ting-ting Zhou; Zhi-yuan Zhu; Jing-jing Zhuang; Xuan Tang; Jing Chen; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

2.  AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550.

Authors:  Min Sung Joo; Won Dong Kim; Ki Young Lee; Ji Hyun Kim; Ja Hyun Koo; Sang Geon Kim
Journal:  Mol Cell Biol       Date:  2016-06-29       Impact factor: 4.272

3.  An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK.

Authors:  Tae Hyun Kim; Jeong Sik Eom; Chan Gyu Lee; Yoon Mee Yang; Yong Sup Lee; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

4.  Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice.

Authors:  Z Yu; W Shao; Y Chiang; W Foltz; Z Zhang; W Ling; I G Fantus; T Jin
Journal:  Diabetologia       Date:  2010-12-16       Impact factor: 10.122

Review 5.  AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability.

Authors:  Yoon Mee Yang; Chang Yeob Han; Yoon Jun Kim; Sang Geon Kim
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

6.  Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer's disease.

Authors:  Dong-Mei Wang; San-Qiang Li; Wen-Lan Wu; Xiao-Ying Zhu; Yong Wang; Hong-Ying Yuan
Journal:  Neurochem Res       Date:  2014-06-04       Impact factor: 3.996

7.  AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor.

Authors:  Eun Hye Jung; Ju-Hee Lee; Sang Chan Kim; Young Woo Kim
Journal:  Eur J Nutr       Date:  2015-12-08       Impact factor: 5.614

Review 8.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

9.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06

10.  Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway.

Authors:  Guang-Zhi Dong; Eun Jeong Jang; Seung Ho Kang; Il Je Cho; Sun-Dong Park; Sang Chan Kim; Young Woo Kim
Journal:  BMC Complement Altern Med       Date:  2013-03-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.